FindTrial
Sign In

GSK2202083A vaccine

BIOLOGICAL4 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaDiphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria MeniHaemophilus Influenzae Type bHepatitis BNeisseria MeningitidisPoliomyelitisTetanus

Phase 2

Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
TerminatedNCT00871741
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +4
Start: 2009-04-01End: 2009-06-25Updated: 2018-06-06
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
CompletedNCT00970307
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni +4
Start: 2009-08-13End: 2010-01-27Updated: 2020-01-03
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
CompletedNCT01090453
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +4
Start: 2010-05-17End: 2011-10-11Updated: 2018-08-20
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
CompletedNCT01171989
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni +4
Start: 2010-08-18End: 2010-12-03Updated: 2020-01-21

Related Papers

A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
2014-12-014 citations
A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
2013-07-016 citations